Immunotech Biopharm Ltd (6978.HK)

HKD 4.09

(0.49%)

Operating Expenses Summary of Immunotech Biopharm Ltd

Immunotech Biopharm Ltd's latest annual operating expenses in 2023 was 230.54 Million CNY , down -14.24% from previous year.
Immunotech Biopharm Ltd's latest quarterly operating expenses in 2024 Q1 was 57.08 Thousand CNY , down -12.98% from previous quarter.
Immunotech Biopharm Ltd reported a annual operating expenses of 268.83 Million CNY in annual operating expenses 2022, down -19.89% from previous year.
Immunotech Biopharm Ltd reported a annual operating expenses of 335.59 Million CNY in annual operating expenses 2021, down -12.43% from previous year.
Immunotech Biopharm Ltd reported a quarterly operating expenses of 57.08 Thousand CNY for 2024 Q2, down 0.0% from previous quarter.
Immunotech Biopharm Ltd reported a quarterly operating expenses of 58.31 Thousand CNY for 2023 Q1, down -33.98% from previous quarter.

Annual Operating Expenses Chart of Immunotech Biopharm Ltd (2023 - 2018)

Historical Annual Operating Expenses of Immunotech Biopharm Ltd (2023 - 2018)

Year	Operating Expenses	Operating Expenses Growth
2023	230.54 Million CNY	-14.24%
2022	268.83 Million CNY	-19.89%
2021	335.59 Million CNY	-12.43%
2020	383.22 Million CNY	245.68%
2019	110.86 Million CNY	161.28%
2018	42.43 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	57.08 Thousand CNY	-12.98%
2024 Q2	57.08 Thousand CNY	0.0%
2023 Q1	58.31 Thousand CNY	-33.98%
2023 Q2	58.31 Thousand CNY	0.0%
2023 Q3	106.67 Thousand CNY	82.94%
2023 FY	329.96 Million CNY	22.74%
2023 Q4	65.59 Thousand CNY	-38.5%
2022 Q2	70.75 Thousand CNY	0.0%
2022 Q4	88.32 Thousand CNY	0.0%
2022 Q3	88.32 Thousand CNY	24.83%
2022 Q1	70.75 Thousand CNY	-31.98%
2022 FY	268.83 Million CNY	-19.89%
2021 Q2	75.22 Thousand CNY	0.0%
2021 FY	335.59 Million CNY	-12.43%
2021 Q4	104.02 Thousand CNY	0.0%
2021 Q3	104.02 Thousand CNY	38.3%
2021 Q1	75.22 Thousand CNY	-43.75%
2020 FY	383.22 Million CNY	245.68%
2020 Q4	133.72 Thousand CNY	0.0%
2020 Q3	133.72 Thousand CNY	54.53%
2020 Q2	86.53 Thousand CNY	0.0%
2020 Q1	86.53 Thousand CNY	198.74%
2019 Q2	24.74 Thousand CNY	0.0%
2019 Q1	24.74 Thousand CNY	0.0%
2019 Q4	28.96 Thousand CNY	0.0%
2019 FY	110.86 Million CNY	161.28%
2019 Q3	28.96 Thousand CNY	17.04%
2018 FY	42.43 Million CNY	0.0%

Peer Operating Expenses Comparison of Immunotech Biopharm Ltd

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	29.073%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	68.813%